✦ LIBER ✦

Bioreductive drugs for cancer therapy: The search for tumor specificity

✍ Scribed by Gerald E. Adams; Ian J. Stratford

Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 890 KB
Volume: 29
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(94)90267-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer Immune Therapy || Search for Univ

Cancer Immune Therapy || Search for Universal TumorâAssociated T Cell Epitopes

✍ Stuhler, Gernot; Walden, Peter 📂 Article 📅 2002 🏛 Wiley 🌐 German ⚖ 139 KB 👁 1 views

Pancreatic cancer, gene delivery, and ta

Pancreatic cancer, gene delivery, and targets: The search for specificity

✍ Harvey I. Pass 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 356 KB

Neoadjuvant Therapy and Anastomotic Leak

Neoadjuvant Therapy and Anastomotic Leak After Tumor-Specific Mesorectal Excision for Rectal Cancer

✍ Guillaume Martel; Youssuf Al-Suhaibani; Husein Moloo; Fatima Haggar; Martin Frie 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 141 KB

A search for specific cancer antigens in

A search for specific cancer antigens in the organs of cancer patients

✍ V. S. Korosteleva; P. N. Kosyakov 📂 Article 📅 1966 🏛 Springer US 🌐 English ⚖ 228 KB

Some strategies for improving specificit

Some strategies for improving specificity and sensitivity in the analysis of anti-cancer drugs

✍ Larry A. Sternson 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 724 KB

Combination therapy with tumor-lysate pu

Combination therapy with tumor-lysate pulsed dendritic cells and antiangiogenic drug TNP-470 for mouse pancreatic cancer

✍ Junichi Miyazaki; Yoshikazu Tsuzuki; Koji Matsuzaki; Ryota Hokari; Yoshikiyo Oka 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 339 KB

## Abstract Most cases of pancreatic cancer are inoperable when diagnosed. Since immunotherapy and antiangiogenic therapy have been reported to be promising for pancreatic cancer, we examined whether the combination of immunotherapy with dendritic cells (DCs) and the antiangiogenic drug TNP‐470 ind